Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 45pembrolizumab 40Magnetic Resonance Spectroscopy 32Cyclophosphamide 31Biopsy 31fludarabine 27Cetuximab 19Cisplatin 18Carboplatin 18atezolizumab 15Bevacizumab 15Fluorouracil 14venetoclax 13Radiation 13Leucovorin 13fludarabine phosphate 12Radiotherapy 12Gemcitabine 12Pemetrexed 11Oxaliplatin 11Nivolumab 11Cytarabine 10130-nm albumin-bound paclitaxel 10Prednisone 9Paclitaxel 9Irinotecan 9Fulvestrant 9Radiosurgery 8Platinum 8Immunoglobulin G 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Receptors, Vascular Endothelial Growth Factor × 30 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡